Article ISI
GASTRIC CANCER  (2021)

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

Martinez de Castro, Eva; Pericay Pijaume, Carles; Castro Unanua, Natalia; Cano, Juana Maria; Garrido, Marcelo; Sanchez Canovas, Manuel; Limon, Maria Luisa; Longo, Federico; Arias-Martinez, Aranzazu; Sauri, Tamara; Mangas, Monserrat; Gil-Negrete, Aitziber; Calvo, Mariona

Abstract

Background The purpose of our study was to develop an online calculator to estimate the effect of docetaxel triplets (DPF) in first line of advanced gastric cancer (AGC), and to assess the external validity of docetaxel trials in individual patients.

Más información

Título según WOS: External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Título de la Revista: GASTRIC CANCER
Volumen: 24
Número: 2
Editorial: Springer
Fecha de publicación: 2021
Página de inicio: 445
Página final: 456
DOI:

10.1007/S10120-020-01116-X
Notas: ISI